BACKWARD BIFURCATION IN A MATHEMATICAL MODEL OF PI3K/AKT PATHWAYS IN ACUTE MYELOID LEUKEMIA

被引：1

作者：

Adi, Yudi Ari ^{[1
,2
]}

Aryati, Lina ^{[2
]}

Adi-Kusumo, Fajar ^{[2
]}

Hardianti, Mardiah Suci ^{[3
]}

机构：

[1] Univ Ahmad Dahlan, Fac Appl Sci & Technol, Dept Math, Yogyakarta 55191, Indonesia

[2] Univ Gadjah Mada, Fac Math & Nat Sci, Dept Math, Yogyakarta 55281, Indonesia

[3] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Internal Med, Yogyakarta 55281, Indonesia

来源：

ADVANCES IN DIFFERENTIAL EQUATIONS AND CONTROL PROCESSES | 2019年 / 21卷 / 02期

关键词：

AML; mathematical model; backward bifurcation;

D O I：

10.17654/DE021020183

中图分类号：

O29 [应用数学];

学科分类号：

070104 ;

摘要：

This paper investigates a mathematical model of the PI3K/AKT pathway in acute myeloid leukemia (AML) in the absence of protein dephosphorylation and AKT degradation. We perform a bifurcation analysis by using the bifurcation method, which is based on the use of the center manifold theory. We give an explicit condition for the existence of backward and forward bifurcations. Numerical simulations are presented to support analytical results and then discussed from both the mathematical and the medical perspectives.

引用

页码：183 / 199

页数：17

共 50 条

[21] Expression and regulation of survivin in acute myeloid leukemia (AML): Through MEK/ERK and PI3K pathways.
Carter, BZ
Milella, M
Tsao, TY
Wathen, JK
Altieri, DC
Andreeff, M
BLOOD, 2000, 96 (11) : 461A - 461A
[22] PI3K/AKT PATHWAYS IN OVARIAN AND ENDOMETRIAL CANCERS
Sessa, C.
ANNALS OF ONCOLOGY, 2012, 23 : 40 - 40
[23] Small molecule inhibitors against PI3K/Akt/mTOR and NF-kB signaling pathways as a combinatorial approach in acute myeloid leukemia treatment
Deslauriers, A. G.
Reckzeh, K.
Mosbech, A.
Rasmussen, K. D.
Helin, K.
Theilgaard-Moench, K.
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 120 - 120
[24] Discovery of Potent and Selective PI3Kδ Inhibitors for the Treatment of Acute Myeloid Leukemia
Tang, Yongmei
Zheng, Yanan
Hu, Xueping
Zhao, Huajun
Cui, Sunliang
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6638 - 6657
[25] UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation
Wang, Li
Zhao, Shuqin
Wang, Yongling
Liu, Jianying
Wang, Xiaoli
BMC CANCER, 2024, 24 (01)
[26] Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis
Chi-Yang Tseng
Yu-Hsuan Fu
Da-Liang Ou
Jeng-Wei Lu
Hsin-An Hou
Liang-In Lin
Cancer Gene Therapy, 2023, 30 : 1691 - 1701
[27] Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis
Tseng, Chi-Yang
Fu, Yu-Hsuan
Ou, Da-Liang
Lu, Jeng-Wei
Hou, Hsin-An
Lin, Liang-In
CANCER GENE THERAPY, 2023, 30 (12) : 1691 - 1701
[28] Expression of Phosphorylated AKT and PI3 Kinase (PI3K) Isoforms in Childhood Acute Lymphoblastic Leukemia
Lourou, M.
Papakonstanti, E.
Pesmatzoglou, M.
Stiakaki, E.
PEDIATRIC BLOOD & CANCER, 2016, 63 : S118 - S118
[29] Investigating the multifaceted cooperation of autophagy, PI3K/AKT signaling pathways, and INPP4B gene in de novo acute myeloid leukemia patients
Gorji, Mahnaz
Farsani, Mehdi Allahbakhshian
Kargar, Maryam
Garavand, Javad
Mohammadi, Mohammad Hossein
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2024, 72 (02)
[30] IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
Chapuis, Nicolas
Park, Sophie
Leotoing, Laurent
Tamburini, Jerome
Verdier, Frederique
Bardet, Valerie
Green, Alexa S.
Willems, Lise
Agou, Fabrice
Ifrah, Norbert
Dreyfus, Francois
Bismuth, Georges
Baud, Veronique
Lacombe, Catherine
Mayeux, Patrick
Bouscary, Didier
BLOOD, 2010, 116 (20) : 4240 - 4250

← 1 2 3 4 5 →